Showing results (51-60 of 104) with videos related to
Sort By:
Pageof 11
Nature|May 31, 2019
Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophageAlexander J Meeske, Sandra Nakandakari-Higa, Luciano A MarraffiniJournal of Bacteriology|November 5, 2013
Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas systemAsma Hatoum-Aslan, Inbal Maniv, Poulami Samai, et al.Nature|September 2, 2014
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targetingGregory W Goldberg, Wenyan Jiang, David Bikard, et al.Cell Host & Microbe|August 21, 2012
CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infectionDavid Bikard, Asma Hatoum-Aslan, Daniel Mucida, et al.Nucleic Acids Research|January 20, 2022
Different modes of spacer acquisition by the Staphylococcus epidermidis type III-A CRISPR-Cas systemNaama Aviram, Ashley N Thornal, David Zeevi, et al.Nature Biotechnology|January 31, 2013
RNA-guided editing of bacterial genomes using CRISPR-Cas systemsWenyan Jiang, David Bikard, David Cox, et al.RNA Biology|May 20, 2011
Implications of RNA virus-produced miRNAsAndrew Varble, Benjamin R ten OeverThe Journal of Biological Chemistry|August 13, 2013
A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAsAsma Hatoum-Aslan, Poulami Samai, Inbal Maniv, et al.Biorxiv : the Preprint Server for Biology|August 12, 2024
A bacterial TIR-based immune system senses viral capsids to initiate defenseCameron G Roberts, Chloe B Fishman, Dalton V Banh, et al.Nature Communications|July 2, 2025
Deep mutational scanning identifies Cas1 and Cas2 variants that enhance type II-A CRISPR-Cas spacer acquisitionRaphael Hofmann, Calvin Herman, Charlie Y Mo, et al.Pageof 11